The Importance of Glucagon-Like Peptide-2 (GLP-2)in Mesenteric Bloodflow in Humans
1 other identifier
interventional
10
1 country
1
Brief Summary
The purpose of this study is to study the effect of GLP-2 on mesenteric bloodflow in healthy adults by the use of ultrasound., it is the hypothesis that GLP-2 vil increase the bloodflow.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for not_applicable healthy
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
January 1, 2006
CompletedFirst Submitted
Initial submission to the registry
January 6, 2006
CompletedFirst Posted
Study publicly available on registry
January 9, 2006
CompletedSeptember 11, 2006
October 1, 2005
January 6, 2006
September 7, 2006
Conditions
Interventions
Eligibility Criteria
You may qualify if:
- healthy
You may not qualify if:
- use of drugs
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Glostrup University Hospital, Copenhagenlead
- Rigshospitalet, Denmarkcollaborator
- University of Copenhagencollaborator
Study Sites (1)
Rigshospitalet
Copenhagen, Copenhagen City, 2100, Denmark
Study Officials
- PRINCIPAL INVESTIGATOR
Mads Hornum, MD
Glostrup University Hospital, Copenhagen
Central Study Contacts
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- NON RANDOMIZED
- Masking
- NONE
- Purpose
- HEALTH SERVICES RESEARCH
- Intervention Model
- SINGLE GROUP
- Sponsor Type
- OTHER
Study Record Dates
First Submitted
January 6, 2006
First Posted
January 9, 2006
Study Start
January 1, 2006
Last Updated
September 11, 2006
Record last verified: 2005-10